M+W Ensures Your Project’s Success

Icon_Moon.svg The Road to BIO: Day 1

Thursday, June 8, 2017
Massachusetts /// New York
Featured Sponsor: M+W Group
R2B_MW_PM_int_060717.jpeg

Peter Cramer, VP Life Science Facility Design is pictured here discussing M+W's holistic approach to supporting clients' development efforts. Watch the full interview.


Platform for New Drug Delivery

In biopharma, product and process are integral to keeping pace as new technologies emerge. To stay the course, M+W employs a holistic approach in helping our customers reach their development milestones. We truly believe that the whole is greater than the sum of its parts, and we partner with our clients to gain an understanding of their entire process to deliver a comprehensive platform for success.

Modular, Global-Ready Capacity Development Strategy & Standardization

Biologic therapies could replace many front-line treatments 10 years from now, which will necessitate businesses ramp up their research and process capacity. M+W’s core commitment to providing flexible, cost-effective solutions involves implementing scalable designs and platforms that meet the needs of global clients, especially in terms of risk and cost management. Our low-cost modular cleanroom systems facilitate novel product development — including cell and gene therapy — across the world. 

Understanding & Applying Advanced Technologies 

We understand that implementing advanced technologies is a strategy driver, and we support our clients in remaining forward thinking abreast of the latest trends. However, we also know the importance of facilitating continuous process above overly complex systems. As a high-tech engineering company, M+W understands the desire to design solutions with new technology, and we support our clients in taking these novel technologies to market through the most efficient means possible. 

Focused on Best-in-Class Integration

M+W has evolved into a holistic systems integrator that focuses less on the architect and engineer as individual entities, and more on the complementary capabilities of each to drive value into the design process, and facilitate the project as a whole. This comprehensive approach, combined with our flexibility as a service provider, enables better validation commissioning and regulatory outcomes for our clients.

Going Local with a Global Company

M+W is a global operation, with 6,000 employees in more than 30 countries. With facilities from Stuttgart to Singapore, we have an unprecedented ability to leverage delivery models around the world, providing our clients with a global platform to deliver high-performance, high-value capacity on demand. 



 MW.png

About M+W Group

M+W is a leading global high-tech engineering and construction company with 6,000 employees in more than 30 countries, offering a full range of services from concept and design to turnkey solutions. Founded in 1912, M+W leverages extensive in-house technical resources combining process, mechanical and electrical engineering, technology integration, lean construction and commissioning expertise to help customers to reach their goals and strive for new horizons.


 

Peter Cramer

Peter Cramer, AIA, NCARB, LEED AP, is VP Life Science Facility Design at M+W Group with more than 25 years of industry-leading experience in preparing conceptual and basis of design documents for pharmaceutical and biologics clients. He is a leader in designing cGMP-manufacturing facilities for clients around the globe. A facility design subject matter expert and contributing member to ISPE, Peter is a thought leader who specializes in the planning and design of facilities using disposable-single-use and modular technologies.

Q: